
To investigate the effect of maternal body mass index zzso on minor zzso associated additional medication use during pregnancy and the zzso cost zzso 

zzso analysis of case zzso 

zzso zzso zzso referral hospital, Royal zzso zzso zzso zzso Six hundred and zzso women with a singleton pregnancy over four separate time periods in 2007 and zzso 

zzso statistics, zzso and zzso zzso zzso analysis and cost analysis using standard techniques and inflation zzso 

Minor zzso use of medications during pregnancy and zzso incremental costs from the perspective of the National Health Service zzso 

zzso of women were overweight or obese zzso or zzso 25 zzso Higher zzso during the first zzso zzso or zzso 30 zzso compared with zzso zzso zzso was associated with an increased risk of minor complications including zzso zzso dysfunction zzso zzso zzso zzso zzso heartburn zzso zzso zzso zzso zzso and chest infection zzso zzso zzso zzso and with drugs used to treat these complications including zzso zzso zzso zzso zzso zzso The mean incremental zzso zzso costs per woman for treating minor complications increased with maternal zzso were zzso zzso zzso zzso and zzso zzso for zzso zzso zzso zzso or zzso 25 to zzso zzso and zzso or zzso 30 zzso zzso 

Increased maternal zzso is associated with increased risk of developing minor complications during zzso use of medications associated with treating these conditions and has significant zzso zzso 

